ALFA Finder| Management target | Revenue 10.0% FY27 |
|---|
| Revenue growth | 9.48% YoY in Q1 FY27. |
|---|---|
| Margins | Higher raw/packing material costs; price hikes taken to offset. |
| Demand visibility | Strong in Women's Hygiene; soft in Pain Management rubs. |
| Management confidence | High for double-digit annual growth. |
Growth
Net Sales grew to 102.97 Cr from 94.05 Cr. PAT fell to 4.37 Cr from 8.31 Cr due to exceptional items.
Outlook
Targeting double-digit revenue and profit growth for FY27. Projecting 15 Cr from razors and 10 Cr from Plastry.
Risks
Pain management volume de-growth (-3.4%), West Asia war impacting COGS, and new FSSAI restrictions on electrolyte drinks.
Investor Presentation filed with NSE, NSE: AMRUTANJAN. Summary written with AI assistance from the document.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹520.15
- Market cap
- ₹1,504 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 26.2×Sector 43.8×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 3.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Investor Presentation: Key Takeaways
Q2 FY27 net sales ₹135.2 Cr (+14.9%), PAT ₹17.3 Cr (+23.8%). H1 PAT ₹21.7 Cr, down 2.8% on cost pressure.
Amrutanjan Health Care Dividend
Amrutanjan Health Care set November 7, 2026 as the record date for its first FY2026-27 interim dividend. The dividend amount per share is not stated.
Amrutanjan Health Care Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 23.6% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹135.2 Cr (+14.9% YoY) and net profit of ₹17.3 Cr (+23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹17.3 Cr · +23.6% YoY
Amrutanjan Health Care Board Meeting Date
Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.
Amrutanjan Health Care Other Announcement
Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.